Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Vicplas InternationalSGX:569 Interest Coverage is 0 (At Loss) as of Jan. 2026. The stock has 5 warning signs investors should review. Among 463 Medical Devices & Instruments companies, Vicplas International ranks worse than 215982.51% on this metric.
Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's
Operating Income
by its Interest Expense. Vicplas International's
Operating Income
for the
six
months ended in Jan. 2026 was S$-3.9 Mil. Vicplas International's Interest Expense for the
six
months ended in Jan. 2026 was S$-1.0 Mil.
did not have earnings to cover the interest expense.
The higher the ratio, the stronger the company's financial strength is.
The historical rank and industry rank for Vicplas International's Interest Coverage or its related term are showing as below:
SGX:569's Interest Coverage is not ranked *
in the Medical Devices & Instruments industry.
Industry Median: 16.24 * Ranked among companies with meaningful Interest Coverage only.
Vicplas International (SGX:569) Interest Coverage Explanation
Ben Graham requires that a company has a minimum interest coverage of 5 with the companies he invested. If the interest coverage is less than 2, the company is burdened by debt. Any business slow or recession may drag the company into a situation where it cannot pay the interest on its debt.
Interest Coverage is an important factor when GuruFocus ranks a company's overage Financial Strength .
Vicplas International Interest Coverage Related Terms
Vicplas International Interest Coverage Historical Data
* Premium members only.
The historical data trend for Vicplas International's Interest Coverage can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Note: For Interest Coverage, "No debt" indicates no long-term debt. An indication of "No Debt" does not necessarily mean that the company has no long-term debt obligations; it could be due to missing data in the quarterly or annual report. Use caution when interpreting this information.
SGX:569 vs ABT, SYK, MDT: Interest Coverage Comparison
For the Medical Devices subindustry, Vicplas International's Interest Coverage, along with its competitors' market caps and Interest Coverage data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Vicplas International Interest Coverage vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Vicplas International's Interest Coverage distribution charts can be found below:
* The bar in red indicates where Vicplas International's Interest Coverage falls into.
Vicplas International Interest Coverage Calculation
Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income (EBIT) by its Interest Expense:
Vicplas International did not have earnings to cover the interest expense.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
What does a Interest Coverage of 0 (At Loss) mean?
Vicplas International (SGX:569) has a Interest Coverage of 0 (At Loss) as of Jan. 2026. Interest Coverage measures a company's capability to pay interest expenses on its debt. View historical data on Vicplas International and its competitors. According to the industry distribution chart, Vicplas International ranks #999999 out of 463 companies in the Medical Devices & Instruments industry.
Is Vicplas International's Interest Coverage too high?
Vicplas International's current Interest Coverage is 0 (At Loss). Based on the distribution chart, Vicplas International ranks #999999 out of 463 companies in the Medical Devices & Instruments industry, which is in the bottom quartile relative to peers.
How does Vicplas International's Interest Coverage compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, Vicplas International ranks #999999 out of 463 companies for Interest Coverage. This places Vicplas International in the lower half of its industry. The industry median Interest Coverage is 16.24. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Interest Coverage for a Medical Devices & Instruments company?
The median Interest Coverage among Medical Devices & Instruments companies is 16.24, based on 463 companies in the industry. Companies in the top quartile (top 25%) have a Interest Coverage significantly above this median, while those in the bottom quartile fall well below. However, Interest Coverage should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Interest Coverage mean?
A high Interest Coverage can signal that a stock is expensive relative to its fundamentals. Interest Coverage measures a company's capability to pay interest expenses on its debt. View historical data on Vicplas International and its competitors. For the Medical Devices & Instruments industry, the median Interest Coverage is 16.24 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Vicplas International's current Interest Coverage is 0 (At Loss). However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Vicplas International stock overvalued right now?
Based on GuruFocus' analysis, Vicplas International (SGX:569) is currently considered Possible Value Trap. The stock's GF Value™ is S$0.11, compared to a current price of S$0.08 — trading 30% below its estimated fair value. The current Interest Coverage is 0 (At Loss). Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Interest Coverage calculated?
Interest Coverage is calculated from a company's financial statements. For Vicplas International (SGX:569), the current Interest Coverage is 0 (At Loss) as of Jan. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Vicplas International Ltd is an investment holding company. The company is organized into two main business activities: the Pipes and Pipe Fitting segment and the Medical Devices segment, which is the key revenue driver. Pipes and Pipe Fittings segment engages in the manufacturing and distribution of plastic building products, including uPVC pipes and pipe fittings and electrical conduits. The Medical device segment is involved in the research, design, development, and manufacture of medical devices. The company generates majority of its revenue from medical devices. The company does its sales through geographical segments that include Singapore, Malaysia, Mexico, China, and the United Kingdom, of which the majority of the revenue comes from Singapore.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
SGX:569 has been successfully added to your 
